Signaling pathways controling prion neurotoxicity: Role of endoplasmic reticulum stress-mediated apoptosis

Neurodegeneration and Prion Disease

Volumn , Issue , 2005, Pages 319-344

  Morales, Rodrigo ^a   Hetz, Claudio ^b   Soto, Claudio ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b UNIVERSITY OF CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84880802609     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/0-387-23923-5_13     Document Type: Chapter

References (136)

1. G. Majno and I. Joris, Apoptosis, Oncosis, and Necrosis - An Overview of Cell-Death. Am. J. Pathol. 146, 3-15 (1995).
2. M. Castedo, J. L. Perfettini, T. Roumier, K. Andreau, R. Medema, and G. Kroemer, Cell death by mitotic catastrophe: a molecular definition. Oncogene 23, 2825-2837 (2004).
3. J. Yuan, M. Lipinski, and A. Degterev, Diversity in the mechanisms of neuronal cell death. Neuron 40, 401-413 (2003).
4. R. A. Lockshin and C. M. Williams, Programmed cell death I-Cytology of degeneration in the intersegmental muscles of the Pernyi Silknoth. J. Insect Physiol 11, 123-133 (1965).
5. J. F. Kerr, A. H. Wyllie, and A. R. Currie, Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26, 239-257 (1972).
6. D. L. Vaux and S. J. Korsmeyer, Cell death in development. Cell 96, 245-254 (1999).
7. C. Soto, Unfolding the role of Protein Misfolding in Neurodegenerative Diseases. Nature Rev. Neurosci. 4, 49-60 (2003).
8. J. Castilla, C. Hetz, and C. Soto, Molecular mechanisms of neurotoxicity of pathological prion protein. Curr. Mol. Med. 4, 397-403 (2004).
9. J. Collinge, Prion diseases of humans and animals: their causes and molecular basis. Annu. Rev. Neurosci. 24, 519-550 (2001).
10. S. B. Prusiner, Prions. Proc. Natl. Acad. Sci. U. S. A. 95, 13363-13383 (1998).
11. K. M. Pan, M. Baldwin, J. Nguyen, M. Gasset, A. Serban, D. Groth, I. Mehlhorn, Z. Huang, R. J. Fletterick, F. E. Cohen and S. B. Prusiner, Conversion of alphahelices into beta-sheets features in the formation of the scrapie prion proteins. Proc. Natl. Acad. Sci. U. S. A. 90, 10962-10966 (1993).
12. F. E. Cohen and S. B. Prusiner,. Pathologic conformations of prion proteins. Annu. Rev. Biochem. 67, 793-819 (1998).
13. N. Streichenberger, D. Jordan, I. Verejan, C, Souchier, F. Philippeau, E. Gros, C. Mottolese, K. Ostrowsky, A. Perret-Liaudet, J. L. Laplanche, M. Hermier, J. P. Deslys, G. Chazot and N. Kopp, The first case of new variant Creutzfeldt-Jakob disease in France: clinical data and neuropathological findings. Acta Neuropathol. (Berl) 99, 704-708 (2000).
14. G. Chazot, E. Broussolle, C. Lapras, T. Blattler, A. Aguzzi and N. Kopp, New variant of Creutzfeldt-Jakob disease in a 26-year-old French man. Lancet 347, 1181 (1996).
15. H. Büeler, A. Aguzzi, A. Sailer, R. A. Greiner, P. Autenried, M. Aguet and C. Weissmann, Mice devoid of PrP are resistant to scrapie. Cell 73, 1339-1347 (1993).
16. D. A. Kocisko, J. H. Come, S. A. Priola, B. Chesebro, G. J. Raymond, P. T. Lansbury and B. Caughey, Cell-free formation of protease-resistant prion protein. Nature 370, 471-474 (1994).
17. G. P. Saborio, B. Permanne and C. Soto, Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 411, 810-813 (2001).
18. C. Hetz and C. Soto, Protein misfolding and disease: the case of prion disorders. Cell Mol. Life Sci. 60, 133-143 (2003).
19. P. J. Lucassen, A. Williams, W. C. Chung and H. Fraser, Detection of apoptosis in murine scrapie. Neurosci. Lett. 198, 185-188 (1995).
20. A. Giese, M. H. Groschup, B. Hess and H. A. Kretzschmar, Neuronal cell death in scrapie-infected mice is due to apoptosis. Brain Pathol. 5, 213-221 (1995).
21. D. Jesionek-Kupnicka, R. Kordek, J. Buczynski and P. P. Liberski, Apoptosis in relation to neuronal loss in experimental Creutzfeldt-Jakob disease in mice. Acta Neurobiol. Exp. (Wars.) 61, 13-19 (2001).
22. A. Dorandeu, L. Wingertsmann, F. Chretien, M. B. Delisle, C. Vital, P. Parchi, P. Montagna, E. Lugaresi, J. W. Ironside H. Budka, P. Gambetti and F. Gray, Neuronal apoptosis in fatal familial insomnia. Brain Pathol. 8, 531-537 (1998).
23. I. Ferrer, Nuclear DNA fragmentation in Creutzfeldt-Jakob disease: does a mere positive in situ nuclear end-labeling indicate apoptosis? Acta Neuropathol. (Berl) 97, 5-12 (1999).
24. F. Gray, H. Adle-Biassette, F. Chretien, T. Ereau, M. B. Delisle and C. Vital, [Neuronal apoptosis in human prion diseases]. Bull. Acad. Natl. Med. 183, 305-320 (1999).
25. F. Gray, F. Chretien, H. Adle-Biassette, A. Dorandeu, T. Ereau, M. B. Delisle, N. Kopp, J. W. Ironside, C. Vital, Neuronal apoptosis in Creutzfeldt-Jakob disease. J. Neuropathol. Exp. Neurol. 58, 321-328 (1999).
26. A. Williams, P. J. Lucassen, D. Ritchie and M. Bruce, PrP deposition, microglial activation, and neuronal apoptosis in murine scrapie. Exp. Neurol. 144, 433-438 (1997).
27. D. W. Fairbairn, K. G. Carnahan, R. N. Thwaits, R. V. Grigsby, G. R. Holyoak and K. L. O'Neill, Detection of apoptosis induced DNA cleavage in scrapie-infected sheep brain. FEMS Microbiol. Lett. 115, 341-346 (1994).
28. D. Theil, R. Fatzer, R. Meyer, M. Schobesberger, A. Zurbriggen and M. Vandevelde, Nuclear DNA fragmentation and immune reactivity in bovine spongiform encephalopathy. J. Comp Pathol. 121, 357-367 (1999).
29. F. Chretien, A. Dorandeu, H. Adle-Biassette, T. Ereau, L. Wingertsmann, F. Brion, F. Gray, [A process of programmed cell death as a mechanisms of neuronal death in prion diseases]. Clin. Exp. Pathol. 47, 181-191 (1999).
30. D. Jesionek-Kupnicka, J. Buczynski, R. Kordek, T. Sobow, I. Kloszewska, W. Papierz and P. P. Liberski, Programmed cell death (apoptosis) in Alzheimer's disease and Creutzfeldt-Jakob disease. Folia Neuropathol. 35, 233-235 (1997).
31. T. Ookohchi, H. Ito, T. Serikawa and K. Sato, Detection of apoptosis in the brain of the zitter rat with genetic spongiform encephalopathy. Biochem. Mol. Biol. Int. 41, 279-284 (1997).
32. S. Siso, B. Puig, R. Varea, E. Vidal, C. Acin, M. Prinz, F. Montrasio, J. Badiola, A. Aguzzi, M. Pumarola and I. Ferrer. Abnormal synaptic protein expression and cell death in murine scrapie. Acta Neuropathol. (Berl) 103, 615-626 (2002).
33. D. Jesionek-Kupnicka, J. Buczynski, R. Kordek and P. P. Liberski, Neuronal loss and apoptosis in experimental Creutzfeldt-Jakob disease in mice. Folia Neuropathol. 37, 283-286 (1999).
34. R. Chiesa, P. Piccardo, B. Ghetti and D. A. Harris, Neurological illness in transgenic mice expressing a prion protein with an insertional mutation. Neuron 21, 1339-1351 (1998).
35. S. Lehmann and D. A. Harris, A mutant prion protein displays an aberrant membrane association when expressed in cultured cells. J. Biol. Chem. 270, 24589-24597 (1995).
36. S. Lehmann and D. A. Harris, Two mutant prion proteins expressed in cultured cells acquire biochemical properties reminiscent of the scrapie isoform. Proc. Nat l. Acad. Sci. U. S. A. 93, 5610-5614 (1996).
37. N. Daude, S. Lehmann and D. A. Harris, Identification of intermediate steps in the conversion of a mutant prion protein to a scrapie-like form in cultured cells. J. Biol. Chem. 272, 11604-11612 (1997).
38. R. Chiesa, B. Drisaldi, E. Quaglio, A. Migheli, P. Piccardo, B. Ghetti and D. A. Harris, Accumulation of protease-resistant prion protein (PrP) and apoptosis of cerebellar granule cells in transgenic mice expressing a PrP insertional mutation. Proc. Natl. Acad. Sci. U. S. A. 97, 5574-5579 (2000).
39. S. Supattapone, P. Bosque, T. Muramoto, H. Wille, C. Aagaard, D. Peretz, H. O. Nguyen, C. Heinrich, M. Torchia, J. Safar, F. E. Cohen, S. J. DeArmond, S. B. Prusiner and M. Scott, Prion protein of 106 residues creates an artificial transmission barrier for prion replication in transgenic mice. Cell, 96, 869-878 (1999).
40. S. Supattapone, E. Bouzamondo, H. L. Ball, H. Wille, H. O. Nguyen, F. E. Cohen, S. J. DeArmond, S. B. Prusiner and M. Scott, A protease-resistant 61-residue prion peptide causes neurodegeneration in transgenic mice. Mol. Cell Biol. 21, 2608-2616 (2001).
41. R. S. Hegde, J. A. Mastrianni, M. R. Scott, K. D. Defea, P. Tremblay, M. Torchia, S. J. DeArmond, S. B. Prusiner and V. R. Lingappa, A transmembrane form of the prion protein in neurodegenerative disease. Science 279, 827-834 (1998).
42. C. Hetz, K. Maundrell and C. Soto, Is loss of function of the prion protein the cause of prion disorders? Trends Mol. Med. 9, 237-243 (2003).
43. C. Hetz, S. Benavent, S. Bieler and C. Soto, (2003). Prion Protein Misfolding and Brain Degeneration. Curr. Med. Chem. 3, 137-147.
44. A. Eastman, Survival Factors, Intracellular Signal-Transduction, and the Activation of Endonucleases in Apoptosis. Seminars Cancer Biol. 6, 45-52 (1995).
45. A. M. Davies, Regulation of neuronal survival and death by extracellular signals during development. EMBO J. 22, 2537-2545 (2003).
46. A. Ashkenazi and V. M. Dixit, Death receptors: Signaling and modulation. Science 281, 1305-1308 (1998).
47. K. F. Ferri and G. Kroemer, Organelle-specific initiation of cell death pathways. Nature Cell Biology 3, E255-E263 (2001).
48. T. Dragovich, C. M. Rudin and C. B. Thompson, Signal transduction pathways that regulate cell survival and cell death., Oncogene. 1998 Dec. 24;17(25):3207-13.
49. L. E. French and J. Tschopp, Protein-based therapeutic approaches targeting death receptors. Cell Death and Dif ferentiation 10, 117-123 (2003).
50. H. Mehmet, Caspases find a new place to hide. Nature 403, 29-30 (2000).
51. M. S. Forman, V. M. Lee and J. Q. Trojanowski, 'Unfolding' pathways in neurodegenerative disease. Trends Neurosci. 26, 407-410 (2003).
52. A. Degterev, M. Boyce and J. Y. Yuan, A decade of caspases. Oncogene 22, 8543-8567 (2003).
53. S. J. Kang, S. Wang, H. Hara, E. P. Peterson, S. Namura, S. Amin-Hanjani, Z. Huang, A. Srinivasan, K. J. Tomaselli, N. A. Thornberry, M. A. Moskowitz and J. Yuan, Dual role of caspase-11 in mediating activation of caspase-1 and caspase-3 under pathological conditions. J. Cell Biol. 149, 613-622 (2000).
54. Y. Tsujimoto, Role of Bcl-2 family proteins in apoptosis: apoptosomes or mitochondria?, Genes Cells. 3, 697-707 (1998).
55. K. Kuida, Caspase-9. Int. J. Biochem. Cell Biol. 32, 121-124 (2000).
56. J. G. Pastorino, M. Tafani, R. J. Rothman, A. Marcinkeviciute, J. B. Hoek, J. L. Farber and A. Marcineviciute, Functional consequences of the sustained or transient activation by Bax of the mitochondrial permeability transition pore. J. Biol. Chem. 274, 31734-31739 (1999).
57. S. J. Korsmeyer, (1999). Programmed cell death and the regulation of homeostasis. Harvey Lect. 95, 21-41.
58. N. N. Danial, and S. J. Korsmeyer, Cell death: Critical control points. Cell 116, 205-219 (2004).
59. J. T. Opferman and S. J. Korsmeyer, Apoptosis in the development and maintenance of the immune system. Nature Immunol. 4, 410-415 (2003).
60. A. M. Ranger, B. A. Malynn, and S. J. Korsmeyer, Mouse models of cell death. Nature Gen. 28, 113-118 (2001).
61. J. N. Gass, K. E. Gunn, R. Sriburi and J. W. Brewer, Stressed-out B cells? Plasmacell differentiation and the unfolded protein response. Trends Immunol. 25, 17-24 (2004).
62. R. J. Kaufman, Orchestrating the unfolded protein response in health and disease. J. Clin. Invest. 110, 1389-1398 (2002).
63. D. T. Rutkowski and R. J. Kaufman, A trip to the ER: coping with stress. Trends Cell Biol. 14, 20-28 (2004).
64. A. J. L. Macario, Heat-Shock Proteins and Molecular Chaperones- Implications for Pathogenesis, Diagnostics, and Therapeutics. Int. J. Clin. Lab. Res. 25, 59-70 (1995).
65. H. Liu, R. C. Bowes 3rd, B. van de Water, C. Sillence, J. F. Nagelkerke and J. L. Stevens, Endoplasmic reticulum chaperones GRP78 and calreticulin prevent oxidative stress, Ca2+ disturbances, and cell death in renal epithelial cells. J. Biol. Chem. 272, 21751-21759 (1997).
66. K. J. Travers, C. K. Patil, L. Wodicka, D. J. Lockhart, J. S. Weissman and P. Walter, Functional and genomic analyses reveal an essential coordination between the unfolded protein response and ER-associated degradation. Cell 101, 249-258 (2000).
67. M. Molinari and A. Helenius, Chaperone selection during glycoprotein translocation into the endoplasmic reticulum. Science 288, 331-333 (2000).
68. W. Paschen, Endoplasmic reticulum: a primary target in various acute disorders and degenerative diseases of the brain. Cell Calcium 34, 365-383 (2003).
69. D. T. Rutkowski and R. J. Kaufman, A trip to the ER: coping with stress. Trends Cell Biol. 14, 20-28 (2004).
70. R. V. Rao, S. Castro-Obregon, H. Frankowski, M. Schuler, V. Stoka, G. del Rio, D. E. Bredesen and H. M. Ellerby, Coupling endoplasmic reticulum stress to the cell death program: role of the ER chaperone GRP78. FEBS Lett. 514, 122-128 (2002).
71. R. K. Reddy, C. Mao, P. Baumeister, R. C. Austin, R. J. Kaufman, A. S. Lee, Endoplasmic reticulum chaperone protein GRP78 protects cells from apoptosis induced by topoisomerase inhibitors-Role of ATP binding site in suppression of caspase-7 activation. J. Biol. Chem. 278, 20915-20924 (2003).
72. R. K. Reddy, J. Lu and A. S. Lee, The endoplasmic reticulum chaperone glycoprotein GRP94 with Ca (2+)-binding and antiapoptotic properties is a novel proteolytic target of calpain during etoposide-induced apoptosis. J. Biol. Chem. 274, 28476-28483 (1999).
73. D. C. Sullivan, L. Huminiecki, J. W. Moore, J. J. Boyle, R. Poulsom, D. Creamer, J. Barker and R. Bicknell, EndoPDI, a novel protein-disulfide isomerase-like protein that is preferentially expressed in endothelial cells acts as a stress survival factor. J. Biol. Chem. 278, 47079-47088 (2003).
74. Y. Bando, T. Katayama, K. Kasai, M. Taniguchi, M. Tamatani and M. Tohyama, GRP94 (94 kDa glucose-regulated protein) suppresses ischemic neuronal cell death against ischemia/reperfusion injury. Eur. J. Neurosci. 18, 829-840 (2003).
75. H. Miyake, I. Hara, S. Arakawa and S. Kamidono, Stress protein GRP78 prevents apoptosis induced by calcium ionophore, lonomycin, but not by glycosylation inhibitor, tunicamycin, in human prostate cancer cells. J. Cell Biochem 77, 396-408 (2000).
76. Z. Yu, H. Luo, W. Fu and M. P. Mattson, The endoplasmic reticulum stressresponsive protein GRP78 protects neurons against excitotoxicity and apoptosis: suppression of oxidative stress and stabilization of calcium homeostasis. Exp. Neurol. 155, 302-314 (1999).
77. T. Nakagawa, H. Zhu, N. Morishima, E. Li, J. Xu, B. A. Yankner and J. Yuan, Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature 403, 98-103 (2000).
78. T. Yoneda, K. Imaizumi, K. Oono, D. Yui, F. Gomi, T. Katayama and M. Tohyama, Activation of caspase-12, an endoplastic reticulum (ER) resident caspase, through tumor necrosis factor receptor-associated factor 2-dependent mechanism in response to the ER stress. J. Biol. Chem. 276, 13935-13940 (2001).
79. F. Urano, X. Wang, A. Bertolotti, Y. Zhang, P. Chung, H. P. Harding and D. Ron, Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. Science 287, 664-666 (2000).
80. X. Z. Wang, H. P. Harding, Y. Zhang, E. M. Jolicoeur, M. Kuroda and D. Ron, (1998). Cloning of mammalian Ire1 reveals diversity in the ER stress responses. EMBO J. 17, 5708-5717.
81. R. V. Rao, A. Peel, A. Logvinova, G. del Rio, E. Hermel, T. Yokota, P. C. Goldsmith, L. M. Ellerby, H. M. Ellerby and D. E. Bredesen, Coupling endoplasmic reticulum stress to the cell death program. Mechanism of caspase activation. J. Biol. Chem. 276, 33869-33874 (2001).
82. E. Fujita, Y. Kouroku, A. Jimbo, A. Isoai, K. Maruyama and T. Momoi, Caspase-12 processing and fragment translocation into nuclei of tunicamycin-treated cells. Cell Death Dif f. 9, 1108-1114 (2002).
83. T. Nakagawa and J. Yuan, Cross-talk between two cysteine protease families. Activation of caspase-12 by calpain in apoptosis. J Cell Biol. 150, 887-894 (2000).
84. N. Morishima, K. Nakanishi, H. Takenouchi, T. Shibata and Y. Yasuhiko, An endoplasmic reticulum stress-specific caspase cascade in apoptosis-Cytochrome c-independent activation of caspase-9 by caspase-12. J. Biol. Chem. 277, 34287-34294 (2002).
85. M. Kilic, R. Schafer, J. Hoppe and U. Kagerhuber, Formation of noncanonical high molecular weight caspase-3 and -6 complexes and activation of caspase-12 during serum starvation induced apoptosis in AKR-2B mouse fibroblasts. Cell Death. Dif fer. 9, 125-137 (2002).
86. J. Hoppe, M. Kilic, V. Hoppe, A. Sachinidis, and U. Kagerhuber, Formation of caspase-3 complexes and fragmentation of caspase-12 during anisomycininduced apoptosis in AKR-2B cells without aggregation of Apaf-1. Eur. J. Cell Biol. 81, 567-576 (2002).
87. J. Hitomi, T. Katayama, Y. Eguchi, T. Kudo, M. Taniguchi, Y. Koyama, T. Manabe S. Yamagishi, Y. Bando, K. Imaizumi, Y. Tsujimoto and M. Tohyama, Involvement of caspase-4 in endoplasmic reticulum stress-induced apoptosis and A beta-induced cell death. J. Cell Biol. 165, 347-356 (2004).
88. G. Zanusso, R. B. Petersen, T. Jin, Y. Jing, R. Kanoush, S. Ferrari, P. Gambetti, and N. Singh, Proteasomal degradation and N-terminal protease resistance of the codon 145 mutant prion protein. J. Biol. Chem. 274, 23396-404 (1999).
89. N. Singh, G. Zanusso, S. G. Chen, H. Fujioka, S. Richardson, P. Gambetti, and R. B. Petersen, Prion protein aggregation reverted by low temperature in transfected cells carrying a prion protein gene mutation. J. Biol. Chem. 272, 28461-70 (1997).
90. T. Jin, Y. Gu, G. Zanusso, M. Sy, A. Kumar, M. Cohen, P. Gambetti, and N. Singh, The chaperone protein BiP binds to a mutant prion protein and mediates its degradation by the proteasome. J Biol Chem. 275, 38699-704 (2000).
91. J. Ma, R. Wollmann and S. Lindquist, Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol. Science 298, 1781-1785 (2002).
92. J. Ma and S. Lindquist, Conversion of PrP to a self-perpetuating PrPSc-like conformation in the cytosol. Science 298, 1785-1788 (2002).
93. D. E. Dimcheff J. L. Portis, and B. Caughey, Prion proteins meet protein quality control. Trends Cell Biol. 13, 337-340 (2003).
94. Y. Yedidia, L. Horonchik, S. Tzaban, A. Yanai and A. Taraboulos, Proteasomes and ubiquitin are involved in the turnover of the wild-type prion protein. EMBO J. 20, 5383-5391 (2001).
95. J. Ma and S. Lindquist, Wild-type PrP and a mutant associated with prion disease are subjectto retrograde transport and proteasome degradation. Proc. Nat l. Acad. Sci. U. S. A. 98, 14955-14960 (2001).
96. B. Drisaldi, R. S. Stewart, C. Adles, L. R. Stewart, E. Quaglio, E. Biasini, L. Fioriti, R. Chiesa and D. A. Harris, Mutant PrP is delayed in its exit from the endoplasmic reticulum, but neither wild-type nor mutant PrP undergoes retrotranslocation prior to proteasomal degradation. J. Biol. Chem. 278, 21732-21743 (2003).
97. C. Bate, S. Reid and A. Williams, Killing of prion-damaged neurones by microglia. Neuroreport 12, 2589-2594 (2001).
98. K. Post, D. R. Brown, M. Groschup, H. A. Kretzschmar and D. Riesner, Neurotoxicity but not infectivity of prion proteins can be induced reversibly in vitro. Arch. Virol. Suppl 16 265-273 (2000).
99. C. Bate, M. Salmona, L. Diomede and A. Williams, Squalestatin cures prioninfected neurons and protects against prion neurotoxicity. J. Biol. Chem. 279, 14983-14990 (2004).
100. W. E. Müller, H. Ushijima, H. C. Schroder, J. M. Forrest, W. F. Schatton, P. G. Rytik and M. Heffner-Lauc, Cytoprotective effect of NMDA receptor antagonists on prion protein (PrionSc)-induced toxicity in rat cortical cell cultures. Eur. J. Pharmacol. 246, 261-267 (1993).
101. S. Tanaka, T. Uehara and Y. Nomura, Up-regulation of protein-disulfide isomerase in response to hypoxia/brain ischemia and its protective effect against apoptotic cell death. J. Biol. Chem. 275, 10388-10393 (2000).
102. H. S. Ko, T. Uehara and Y. Nomura, Role of ubiquilin associated with proteindisulfide isomerase in the endoplasmic reticulum in stress-induced apoptotic cell death. J. Biol. Chem. 277, 35386-35392 (2002).
103. J. Ma and S. Lindquist, De novo generation of a PrPSc-like conformation in living cells. Nat. Cell Biol. 1, 358-361 (1999).
104. R. Lucassen, K. Nishina and S. Supattapone, In vitro amplification of proteaseresistant prion protein requires free sulfhydryl groups. Biochemistry 42, 4127-4135 (2003).
105. Tompa, P., Tusnady, G. E., Friedrich, P., and Simon, I. The role of dimerization in prion replication. Biophys. J. 82, 1711-1718 (2002).
106. O. Ghribi, M. M. Herman, D. A. DeWitt, M. S. Forbes and J. Savory, Abeta (1-42) and aluminum induce stress in the endoplasmic reticulum in rabbit hippocampus, involving nuclear translocation of gadd 153 and NF-kappaB. Brain Res. Mol. Brain Res. 96, 30-38 (2001).
107. O. Ghribi, M. M. Herman, and J. Savory, Lithium inhibits Abeta-induced stress in endoplasmic reticulum of rabbit hippocampus but does not prevent oxidative damage and tau phosphorylation. J. Neurosci. Res. 71, 853-862 (2003).
108. F. Terro, C. Czech, F. Esclaire, W. Elyaman, C. Yardin, M. C. Baclet, N. Touchet, G. Tremp, L. Pradier and J. Hugon, Neurons overexpressing mutant presenilin-1 are more sensitive to apoptosis induced by endoplasmic reticulum-Golgi stress. J. Neurosci. Res. 69, 530-539 (2002).
109. S. L. Chan, C. Culmsee, N. Haughey, W. Klapper and M. P. Mattson, Presenilin-1 mutations sensitize neurons to DNA damage-induced death by a mechanism involving perturbed calcium homeostasis and activation of calpains and caspase-12. Neurobiol. Dis. 11, 2-19 (2002).
110. O. Milhavet, J. L. Martindale, S. Camandola, S. L. Chan, D. S. Gary, A. Cheng, N. J. Holbrook, M. P. Mattson, Involvement of Gadd153 in the pathogenic action of presenilin-1 mutations. J. Neurochem. 83, 673-681 (2002).
111. Y. Yasuda, T. Kudo, T. Katayama, K. Imaizumi, M. Yatera, M. Okochi, H. Yamamori, N. Matsumoto, T. Kida, A. Fukumori, M. Okumura, M. Tohyama and M. Takeda, FAD-linked presenilin-1 mutants impede translation regulation under ER stress. Biochem. Biophys. Res. Commun. 296, 313-318 (2002).
112. H. Nishitoh, A. Matsuzawa, K. Tobiume, K. Saegusa, I. Takeda K,. Inoue, S. Hori, A. Kakizuka and H. Ichijo, ASK1 is essential for endoplasmic reticulum stressinduced neuronal cell death triggered by expanded polyglutamine repeats. Genes and Development 16, 1345-1355 (2002).
113. Y. Kouroku, E. Fujita, A. Jimbo, T. Kikuchi, T. Yamagata, M. Y. Momoi, E. Kominami, K. Kuida, K. Sakamaki, S. Yonehara and T. Momoi, Polyglutamine aggregates stimulate ER stress signals and caspase-12 activation. Hum. Mol. Genet. 11, 1505-1515 (2002).
114. Tsai, Y. C., Fishman, P. S., Thakor, N. V., and Oyler, G. A. Parkin facilitates the elimination of expanded polyglutamine proteins and leads to preservation of proteasome function. J. Biol. Chem. 278, 22044-22055 (2003).
115. H. L. Paulson, M. K. Perez, Y. Trottier, J. Q. Trojanowski, S. H. Subramony, S. S. Das, P. Vig, J. L. Mandel, K. H. Fischbeck and R. N. Pittman, Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3. Neuron 19, 333-344 (1997).
116. T. M. Dawson and V. L. Dawson, Molecular pathways of neurodegeneration in Parkinson's disease. Science 302, 819-822 (2003).
117. W. Dauer and S. Przedborski, Parkinson's disease: Mechanisms and models. Neuron 39, 889-909 (2003).
118. W. A. Holtz and K. L. O'Malley, Parkinsonian mimetics induce aspects of unfolded protein response in death of dopaminergic neurons. J. Biol. Chem. 278, 19367-19377 (2003).
119. E. J. Ryu, H. P. Harding, J. M. Angelastro, O. V. Vitolo, D. Ron and L. A. Greene, (2002). Endoplasmic reticulum stress and the unfolded protein response in cellular models of Parkinson's disease. J. Neurosci. 22, 10690-10698.
120. R. E. Burke, Recent advances in research on Parkinson disease: Synuclein and parkin. Neurologist 10, 75-81 (2004).
121. D. E. Dimcheff, S. Askovic, A. H. Baker, C. Johnson-Fowler and J. L. Portis, Endoplasmic reticulum stress is a determinant of retrovirus-induced spongiform neurodegeneration. J. Virol. 77, 12617-12629 (2003).
122. H. T. Kim, K. Waters, G. Stoica, W. Qiang, N. Liu, V. L. Scofield and P. K. Wong, (2004). Activation of endoplasmic reticulum stress signaling pathway is associated with neuronal degeneration in MoMuLV-ts1-induced spongiform encephalomyelopathy. Lab Invest.
123. M. Shibata, H. Hattori, T. Sasaki, J. Gotoh J. Hamada and Y. Fukuuchi, Activation of caspase-12 by endoplasmic reticulum stress induced by transient middle cerebral artery occlusion in mice. Neuroscience 118, 491-499 (2003).
124. G. Mouw, J. L. Zechel, J. Gamboa, W. D. Lust, W. R. Selman and R. A. Ratcheson, Activation of caspase-12, an endoplasmic reticulum resident caspase, after permanent focal ischemia in rat. Neuroreport 14, 183-186 (2003).
125. S. F. Larner, R. L. Hayes, D. M. McKinsey, B. R. Pike, and K. K. W. Wang, Increased expression and processing of caspase-12 after traumatic brain injury in rats. J. Neurochem. 88, 78-90 (2004).
126. C. Hetz, M. Russelakis-Carneiro, K. Maundrell, J. Castilla, and C. Soto, Caspase-12 and endoplasmic reticulum stress mediate neurotoxicity of pathological prion protein. EMBO J. 22, 5435-5445 (2003).
127. G. Mallucci, A. Dickinson, J. Linehan, P. C. Klohn, S. Brandner and J. Collinge, Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science. 302, 871-874 (2003).
128. S. Brandner, S. Isenmann, A. Raeber, M. Fischer, A. Sailer, Y. Kobayashi, S. Marino, C. Weissmann and A. Aguzzi, Normal host prion protein necessary for scrapieinduced neurotoxicity. Nature, 379, 339-343, (1996).
129. L. Solforosi, J. R. Criado, D. B. McGavern, S. Wirz, M. Sanchez-Alavez, S. Sugama, L. A. DeGiorgio, B. T. Volpe, E. Wiseman, G. Abalos, E. Masliah, D. Gilden, M. B. Oldstone, B. Conti and R. A. Williamson, Cross-linking cellular prion protein triggers neuronal apoptosis in vivo. Science 303, 1514-1516 (2004).
130. K. Sandvig and B. van Deurs, Transport of protein toxins into cells: pathways used by ricin, cholera toxin and Shiga toxin. FEBS Lett. 529, 49-53 (2002).
131. B. Tsai and T. A. Rapoport, Unfolded cholera toxin is transferred to the ER membrane and released from protein disulfide isomerase upon oxidation by Ero1. J Cell Biol. 159, 207-216 (2002).
132. F. Beranger, A. Mange, B. Goud and S. Lehmann, Stimulation of PrP (C) retrograde transport toward the endoplasmic reticulum increases accumulation of PrP (Sc) in prion-infected cells. J. Biol. Chem. 277, 38972-38977 (2002).
133. T. Nakagawa and J. Yuan, Cross-talk between two cysteine protease families. Activation ofcaspase-12 by calpainin apoptosis. J. Cell Biol. 150, 887-894 (2000).
134. H. Fischer, U. Koenig, L. Eckhart and E. Tschachler, Human caspase 12 has acquired deleterious mutations. Biochem. Biophys. Res. Commun. 293, 722-726 (2002).
135. C. D. Bown, J. F. Wang, B. Chen and L. T. Young, Regulation of ER stress proteins by valproate: therapeutic implications. Bipolar Disorders 4, 145-151 (2002).
136. M. Flores-Diaz, J. C. Higuita, I. Florin, T. Okada, P. Pollesello, T. Bergman, M. Thelestam, K. Mori and A. Alape-Giron, A cellular UDP-glucose deficiency causes overexpression of glucose/oxygen-regulated proteins independent of the endoplasmic reticulum stress elements. J. Biol. Chem. 279, 21724-21731 (2004).